The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Role of Reduced Suppression of Glucose Production and Diminished Early Insulin Release in Impaired Glucose Tolerance
Open accessAbstract
BACKGROUND: Insulin resistance and impaired insulin secretion both occur in non-insulin-dependent diabetes (NIDDM), but their relative importance is unclear. Hyperglycemia itself has adverse effects on tissue insulin sensitivity and insulin secretion that make it difficult to distinguish between primary and secondary abnormalities. To avoid this problem we studied subjects with postprandial glucose intolerance but not sustained hyperglycemia. METHODS: We compared the rate of systemic appearance and disappearance of glucose, the output of endogenous hepatic glucose, splanchnic and muscle uptake of glucose, and plasma insulin and glucagon responses after the ingestion of 1 g of glucose per kilogram of body weight in 15 subjects with impaired glucose tolerance (8 of them nonobese and 7 obese) and in 16 normal subjects (9 nonobese and 7 obese) who were matched for age and weight. RESULTS: After glucose ingestion the mean (+/- SE) rate of total systemic appearance of glucose was significantly higher in both the nonobese subjects (455 +/- 12 mmol per five hours) and the obese subjects (486 +/- 17 mmol per five hours) with impaired glucose tolerance than in the respective normal subjects (411 +/- 11 and 436 +/- 7 mmol per five hours). This difference was fully accounted for by the reduced suppression of endogenous hepatic glucose in the subjects with impaired glucose tolerance (a reduction of about 28 percent, vs. 48 percent in the normal subjects; P less than 0.01). Despite late hyperinsulinemia, at 30 minutes the subjects with impaired glucose tolerance had smaller increases in plasma insulin and smaller reductions in plasma glucagon (both P less than 0.01). Molar ratios of plasma insulin to plasma glucagon levels correlated inversely (r = -0.62, P less than 0.001) with the rates of systemic glucose appearance; the latter correlated positively (r = 0.72, P less than 0.0001) with peak plasma glucose concentrations. CONCLUSIONS: Impaired glucose tolerance, the precursor of NIDDM, results primarily from reduced suppression of hepatic glucose output due to abnormal pancreatic islet-cell function. The late hyperinsulinemia may be the consequence of an inadequate early beta-cell response rather than of insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“As indicated by several studies, insulin resistance leads to basal-fasting hyperinsulinemia, which may result in the insensitivity of beta-cell secretion. This insensitivity leads to a lower first-phase insulin secretion to the rising postprandial glucose but a subsequent exaggerated compensatory second-phase insulin secretion, which might result in hypoglycemia [2, 3].”
From Associated Factors with Biochemical Hypoglycemia during an Oral Glucose Tolerance Test in a Chinese Population (2017) · cites this paper as [3]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“When the first-phase insulin response decreases, firstly, blood glucose starts to rise after the meal, which leads to late but excessive secretion of the second-phase insulin secretion. Thus, late reactive hypoglycemia occurs.[3]”
From Postprandial Reactive Hypoglycemia (2019) · cites this paper as [3]
Experimental — accuracy not yet measuredIn the citing paper
“Indeed, with better matching of subjects for age, sex and obesity, there also does seem to be a decrease of the insulinogenic index in subjects with IGT [5, 87, 88].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [5]
In the citing paper
“This reduction in the early insulin response results in a lack of adequate suppression of hepatic glucose production with subsequent post challenge hyperglycaemia and increased insulin concentrations late in the test [5, 126].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coated Charcoal Immunoassay of Insulin
Herbert, V. D., Lau, K., Gottlieb, C. W., & Bleicher, S. J. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1375 · Cited by 2,969
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*
Perley, M. J., & Kipnis, D. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105685 · Cited by 917
Early Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes Mellitus
Eriksson, J., Franssila-Kallunki, A., Ekstrand, A., Saloranta, C., Widén, E., Schalin, C., & Groop, L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210601 · Cited by 807
Rossetti, L., Giaccari, A., & DeFronzo, R. A. (1990) · Diabetes Care · doi:10.2337/diacare.13.6.610 · Cited by 774
Kolterman, O., Gray, R. S., Griffin, J., BURSTEIN, P. J., Insel, J. R., Scarlett, J. A., & Olefsky, J. M. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110350 · Cited by 628
Impaired Glucose Tolerance as a Disorder of Insulin Action
Lillioja, S., Mott, D. M., Howard, B. V., Bennett, P. H., Yki-Järvinen, H., Freymond, D., Nyomba, B. L., Zurlo, F., Swinburn, B., & Bogardus, C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805123181901 · Cited by 578
METHODS FOR THE INVESTIGATION OF PERIPHERAL BLOOD FLOW
Greenfield, A. D. M., Whitney, R. J., & Mowbray, J. F. (1963) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a070026 · Cited by 494
Andres, R., Cader, G., & Zierler, K. L. (1956) · Journal of Clinical Investigation · doi:10.1172/jci103324 · Cited by 389
Glucagon physiology and pathophysiology in the light of new advances
Unger, R. H. (1985) · Diabetologia · doi:10.1007/bf00281991 · Cited by 361
Research works printed but not linked: 6
- Gerich, 1988, Clin Endocrinol Metab, 2, 307
- Luzi, 1989, Am J Physiol, 257, E241
- 1980, WHO Tech Rep Ser, 646, 1
- Faloona GR, Unger RH. Glucagon. In: Jaffe BM, Behrman HR, eds. Methods of hormone radioimmunoassay. New York: Academic Press, 1974:317–30
- Hetenyi, 1974, Fed Proc, 33, 1841
- Chiasson, 1977, Fed Proc, 36, 229
Cited by
Sorted by citations
Items 401–500 of 593
Jin, S., Choi, S. H., Choi, D.-W., Heo, J. S., Suh, S., Bae, J. C., Kim, J. H., Lee, M., Kim, K., & Lee, M. (2014) · Endocrine · doi:10.1007/s12020-013-0159-9 · Cited by 9
Binnert, C., Seematter, G., Tappy, L., & Giusti, V. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70018-6 · Cited by 9
Nunes, P. M., Jarak, I., Heerschap, A., & Jones, J. G. (2013) · Magnetic Resonance in Medicine · doi:10.1002/mrm.24789 · Cited by 9
Effects of genetic predisposition on proinsulin responses in Asian Indians
Ramachandran, A., Snehalatha, C., Satyavani, K., & Viswanathan, V. (1998) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(98)00060-6 · Cited by 9
Shimodaira, M., Muroya, Y., Kumagai, N., Tsuzawa, K., & Honda, K. (2013) · Journal of Endocrinological Investigation · doi:10.3275/8934 · Cited by 9
The insulin response to gastric glucose is reduced in PAC1 and GRP receptor gene deleted mice
Åhrén, B. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.11.007 · Cited by 9
Abnormalities of Insulin Secretion and β‐Cell Defects in Type 2 Diabetes
Alsahli, M., & Gerich, J. E. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch10 · Cited by 11
Self-citationIgarashi, Y., Mita, T., Mizuno, R., Watada, H., Tanaka, Y., Kawamori, R., & Hirose, T. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.683 · Cited by 9
Esser, N., Utzschneider, K. M., & Kahn, S. E. (2021) · Diabetologia · doi:10.1007/s00125-021-05511-6 · Cited by 9
Rocha, D. S., Dentz, M. C. V., Model, J. F. A., Vogt, É. L., Ohlweiler, R., Lima, M. V., de Souza, S. K., & Kucharski, L. C. (2022) · Biomedical Journal · doi:10.1016/j.bj.2022.05.004 · Cited by 8
Kumar, S. R. S., & Rao, K. V. B. (2018) · Europe PMC (PubMed Central) · Cited by 8
Hiperglicemia pós-prandial: tratamento do seu potencial aterogênico
Geloneze, B., Lamounier, R. N., & Coelho, O. R. (2006) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2006001800018 · Cited by 11
Effect of Tang No.1 granule (糖1号方) in treating patients with impaired glucose tolerance
Wei, Y., Hong, Y., & Ye, X. (2008) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-008-0298-7 · Cited by 8
Kahn, S. E. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2004.02.005 · Cited by 8
Effects of hyperglycemia on glucose metabolism before and after oral glucose ingestion in normal men
Rigalleau, V., Beauvieux, M.-C., Gallis, J., Gin, H., Schneiter, P., & Tappy, L. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00407.2005 · Cited by 8
Thomas, S., Besecker, B. Y., Choe, Y. S., & Christofides, E. (2024) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2024.1399410 · Cited by 8
Sato, M., Tamura, Y., Someya, Y., Takeno, K., Kaga, H., Kadowaki, S., Sugimoto, D., Kakehi, S., Funayama, T., Furukawa, Y., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13245 · Cited by 6
Bloomgarden, Z. T. (2002) · Diabetes Care · doi:10.2337/diacare.25.9.1644 · Cited by 7
Alsahli, M., Shrayyef, M. Z., & Gerich, J. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_2 · Cited by 7
Self-citationTechnosphere Inhaled Insulin: Is Faster Better?
Leahy, J. L. (2015) · Diabetes Care · doi:10.2337/dci15-0002 · Cited by 7
Åhrén, B. (2015) · Diabetes & Metabolism · doi:10.1016/s1262-3636(16)30002-7 · Cited by 7
Higaki, T., Kurisu, S., Watanabe, N., Ikenaga, H., Shimonaga, T., Iwasaki, T., Ishibashi, K., Dohi, Y., Fukuda, Y., & Kihara, Y. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpv120 · Cited by 7
Role of NMDA Receptors in Pancreatic Islets
Scholz, O., Welters, A., & Lammert, E. (2017) · Springer eBooks · doi:10.1007/978-3-319-49795-2_7 · Cited by 9
Kumpatla, S., Parveen, R., Murugan, P., Juttada, U., Devarajan, A., & Viswanathan, V. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102199 · Cited by 7
Sargın, M., IKIISIK, M., Sargın, H., Orçun, A., Müjgan, K. A. Y. A., Gözü, H. I., Dabak, R., Bayramıçlı, O. U., & YAYLA, A. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.531 · Cited by 7
The Effect of Liver Disease on the Endocrine System
Kruszynska, Y. T., & Bouloux, P. M. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch21b · Cited by 7
Tepe, A. S. (2021) · Journal of Chemistry · doi:10.1155/2021/5405365 · Cited by 6
Proposed treatment strategy for reactive hypoglycaemia
Younes, Y. R., Cron, N., Field, B. C. T., Nayyar, V., Clark, J., Zachariah, S., Lakshmipathy, K., Isuga, J., Maghsoodi, N., & Emmanuel, J. J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1332702 · Cited by 6
Primary and secondary insulin resistance
Mokáň, M., & Galajda, P. (2019) · Vnitřní lékařství · doi:10.36290/vnl.2019.045 · Cited by 6
The comparison of second phase insulin secretion in patients treated with repaglinide or gliclazide
Yang, C.-C., Lin, J.-D., Kuo, K., Wu, C., Li, J.-C., Hung, Y. J., Wang, T. F., Lee, C., Kuo, S. W., & Pei, D. (2007) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2006.11.006 · Cited by 6
Nuclear Peroxisome Proliferator-Activated Receptors and Thiazolidinediones
Oren-Grinberg, A., & Park, K. W. (2005) · International Anesthesiology Clinics · doi:10.1097/01.aia.0000157485.91241.0b · Cited by 6
Koopman, A. D. M., Beulens, J. W. J., van der Heijden, A., Elders, P. J. M., Dekker, J. M., Alssema, M., & Rutters, F. (2019) · Clinical Endocrinology · doi:10.1111/cen.13977 · Cited by 6
Flynn, C. R., Albaugh, V. L., Tamboli, R. A., Gregory, J. M., Bosompem, A., Sidani, R. M., & Winnick, J. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00224.2019 · Cited by 6
Georg, P., Kautzky‐Willer, A., Mahdjoobian, K., Hofer, A., Prager, R., Pacini, G., & Ludvik, B. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2042 · Cited by 6
Splanchnic tissues play a crucial role in uremic glucose intolerance
Rigalleau, V., Baillet, L., Lasseur, C., Moreau, K., Chauveau, P., Aparicio, M., Normand, S., Desage, M., Laville, M., Déléris, G., et al. (2003) · Journal of Renal Nutrition · doi:10.1016/s1051-2276(03)00071-2 · Cited by 6
Lindström, J. (2006) · Työväentutkimus Vuosikirja · Cited by 6
Noncanonical Regulation of cAMP‐Dependent Insulin Secretion and Its Implications in Type 2 Diabetes
Ramanadham, S., TURK, J. W., & Bhatnagar, S. (2023) · Comprehensive physiology · doi:10.1002/cphy.c220031 · Cited by 11
Rahman, M. M., Pathak, A., Schueler, K. L., Alsharif, H. A., Michl, A. N., Alexander, J., Kim, J., & Bhatnagar, S. (2023) · The FASEB Journal · doi:10.1096/fj.202300291rr · Cited by 5
Tang, H., & Chen, C. Y. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/385120 · Cited by 5
The effect of Nateglinide taken with food on gastric emptying rates in healthy subjects
Anderson, D., Shelley, S., Kellett, N., Marshall, D., & Nimmo, W. S. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80165-0 · Cited by 5
Soonthornpun, K., Soonthornpun, S., Thamprasit, A., & Aksonteing, J. (2008) · PubMed · Cited by 5
Hypoglycemia and Hypoglycemic Syndromes
Davis, S. N., Lamos, E. M., & Younk, L. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00047-0 · Cited by 5
Troelsen, F. S., Sørensen, H. T., Pedersen, L. H., & Erichsen, R. (2021) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2021-000786 · Cited by 5
Early postprandial Insulin secretion: Its relation to Insulin sensitivity
Kabadi, U. M., & Kabadi, M. U. (2011) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2011.11001 · Cited by 5
The Role of the Liver in Insulin Action and Resistance
Radziuk, J., & Pye, S. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-716-1_11 · Cited by 5
DeFronzo, R. A. (2003) · The British Journal of Diabetes · doi:10.1177/1474651403003001s0601 · Cited by 5
Regulation of Glucose Metabolism in Skeletal Muscle
Kruszynska, Y. T., Ciaraldi, T. P., & Henry, R. R. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070218 · Cited by 5
Paquot, N., Schneiter, P., Scheen, A. J., Lefèbvre, P., & Tappy, L. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801386 · Cited by 5
Bohannon, N. J. V. (1997) · Postgraduate Medicine · doi:10.3810/pgm.1997.02.158 · Cited by 5
Broughton, D., Webster, J. M., & Taylor, R. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01509.x · Cited by 5
Pathogenesis of Type 2 Diabetes
Cusi, K. J., & DeFronzo, R. A. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070237 · Cited by 5
Haggiag, N., Rotman, M., Hallak, M., Toledano, Y., Gabbay-Benziv, R., & Maor-Sagie, E. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133806 · Cited by 4
“Subsequently, there is a delayed and excessive secretion of second-phase insulin, resulting in later postprandial hypoglycemia due to prolonged elevated plasma insulin levels persisting after nutrient metabolism [13,14].”
BackgroundDifferenzierte Insulintherapie des Typ-2-Diabetes
Liebl, A. (2008) · Der Diabetologe · doi:10.1007/s11428-008-0248-1 · Cited by 3
Methods for Quantifying Insulin Sensitivity and Determining Insulin Time-Action Profiles
Krentz, A. J., Heinemann, L., & Hompesch, M. (2014) · Springer eBooks · doi:10.1007/978-1-4471-4920-0_1 · Cited by 5
Selz, R., Jornayvaz, F. R., Tappy, L., Woringer, V., & Theintz, G. E. (2004) · Hormone Research in Paediatrics · doi:10.1159/000080070 · Cited by 4
Islas‐Andrade, S., Revilla, M., de Hurtado, E. M., Alvarez, L. F. C., Caminos, Q. R., Yupanqui, H., López, G., & de la Torre, W. (2003) · Pharmacology · doi:10.1159/000069534 · Cited by 4
Kabadi, U. M. (2013) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2013.33019 · Cited by 4
Dunning, B. E., Deacon, R. W., Gutierrez, C., Paladini, S., Valentin, M., & Foley, J. (2003) · Diabetologia · doi:10.1007/s00125-002-0933-3 · Cited by 4
Review: The importance of effective early phase insulin secretion
Prato, S. D., Miccoli, R., & Penno, G. (2005) · The British Journal of Diabetes · doi:10.1177/14746514050050040401 · Cited by 4
Okahata, S., Sakamoto, K., Mitsumatsu, T., Kondo, Y., Tanaka, S., & Shiba, T. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13505 · Cited by 4
Luyckx, F., & Scheen, A. J. (2003) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/s0923-2532(03)00064-4 · Cited by 4
Weyrich, P., Lammers, R., Fritsche, A., Machicao, F., Häring, H., & Stefan, N. (2005) · Diabetologia · doi:10.1007/s00125-005-1688-4 · Cited by 3
Alsahli, M., & Gerich, J. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.03827-7 · Cited by 6
Self-citationThe Search for Glucagon Antagonists
Amatruda, J. M., & Livingston, J. N. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-61150-6_8 · Cited by 3
Insulin resistance and type 2 diabetes as allostatic responses to chronic nutrient excess
Prentki, M., Nolan, C. J., James, D. E., Thorens, B., Rhodes, C. J., Corkey, B. E., Ling, C., Froguel, P., Mathieu, C., Gautier, J., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.06.012 · Cited by 5
Ando, H., Kurita, S., Shimizu, A., Kato, K., Ishikura, K., Taji, K. N., Uno, M., Takeshita, Y., Misu, H., Fujimura, A., et al. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2012.05708.x · Cited by 3
Lian, W.-C., Lin, J., Chang, J., Hsu, C., Pei, C., Wu, C., Hsieh, C., Pei, D., & Chen, Y. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0042 · Cited by 3
Electronic structure and reactivity of heme bound insulin
Roy, M., Pal, I., Dey, C., Dey, A., & Dey, S. G. (2021) · Journal of Porphyrins and Phthalocyanines · doi:10.1142/s1088424621500346 · Cited by 3
Quantification of Insulin Action in Human Subjects
Krentz, A. J., Weyer, C., & Hompesch, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-11748-1_1 · Cited by 3
Approaches to preventing mealtime hyperglycaemic excursions
Kelley, D. E. (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00172.x · Cited by 3
Self-citationBays, H. E., Mandarino, L. J., & DeFronzo, R. A. (2004) · Cited by 3
Regulation of Insulin Secretion and Islet Cell Function
Weir, G., Bonner-Weir, S., & Sharma, A. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-1028-7_1 · Cited by 4
Xie, L., Hoffman, R. P., & Veng‐Pedersen, P. (2009) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.652 · Cited by 3
Hyperglycaemia in diabetes: impact on nephropathy and cardiac risk
Torffvit, O. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg213 · Cited by 3
Pinkney, J. H., Nagi, D. K., & Yudkin, J. S. (1993) · Vascular Medicine Review · doi:10.1177/1358863x9300400103 · Cited by 3
Kaya, H. K., Şermet, A., Pekkolay, Z., Taşdemir, E., & Keşim, D. A. (2022) · Anatolian Current Medical Journal · doi:10.38053/acmj.1008983 · Cited by 2
He, Q., Cheng, Z., Li, Y., Xing, X., Li, L., Li, X., Zhang, J., Xu, L., Song, W., Li, F., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16096 · Cited by 2
Li, S., Liu, J., Yang, C., Jin, Y., Zhou, Y., Zhao, H., Su, Z., Fu, Y., Zhang, M., Yin, X., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf303 · Cited by 3
Oral anti-diabetic agents in pregnancy: Their time has come
Langer, O. (2008) · Series in maternal-fetal medicine · doi:10.3109/9781439802007.028 · Cited by 2
The Liver, Glucose Homeostasis, and Insulin Action in Type 2 Diabetes Mellitus
Radziuk, J., & Pye, S. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_18 · Cited by 2
[Insulin sensitivity and beta cell function in different glucose tolerance status].
Gómez‐García, A., Magaña-Garns, P., Ruiz-García, J., & Álvarez-Aguilar, C. (2006) · PubMed · Cited by 2
L’hyperglycémie provoquée par voie orale (HGPO) revisitée
Scheen, A. J., & Luyckx, F. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70163-2 · Cited by 2
Wada, R., Koyama, M., Mizukami, H., Odaka, H., Ikeda, H., & Yagihashi, S. (1999) · Diabetes/Metabolism Research and Reviews · doi:10.1002/(sici)1520-7560(199909/10)15:5 · Cited by 29
Review: Mechanisms contributing to the development of type 2 diabetes
Jayapaul, M., & Walker, M. (2004) · The British Journal of Diabetes · doi:10.1177/14746514040040040201 · Cited by 2
Rigalleau, V., Beauvieux, M.-C., Gallis, J., Gin, H., Schneiter, P., & Tappy, L. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.01.007 · Cited by 2
Recent Progress in the Molecular Genetic Aspects of Non-Insulin-Dependent Diabetes Mellitus.
Seino, S. (1996) · Internal Medicine · doi:10.2169/internalmedicine.35.347 · Cited by 2
L’hyperglycémie provoquée par voie orale (HGPO) revisitée
Scheen, A. J., & Luyckx, F. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70124-3 · Cited by 2
Postprandial glucose: the nondiabetic state
Massi‐Benedetti, M., & Orsini-Federici, M. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00015.x · Cited by 2
Fatouros, I. G., & Mitrakou, A. (2012) · CRC Press eBooks · doi:10.1201/b12085-16 · Cited by 2
Self-citationInsulintherapie bei Typ-2-Diabetes
Liebl, A. (2007) · Der Diabetologe · doi:10.1007/s11428-007-0132-4 · Cited by 2
Zimmermann, S., Vogel, M., Mathew, A., Ebert, T., Rana, R., Jiang, S., Isermann, B., & Biemann, R. (2022) · Nutrients · doi:10.3390/nu14153060 · Cited by 2
Investigating paediatric hypoglycaemia: Dynamic studies at a tertiary paediatric hospital
Graves, L. E., Stewart, K., Ambler, G. R., Bhattacharya, K., & Srinivasan, S. (2021) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.15349 · Cited by 2
Rigalleau, V., Beylot, M., Normand, S., Pachiaudi, C., Laville, M., Petitbois, C., Déléris, G., Baillet, L., & Gin, H. (2003) · Annals of Nutrition and Metabolism · doi:10.1159/000070484 · Cited by 2
Jayapaul, M. K., & Walker, M. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02207.x · Cited by 2
Loss of glucose homoeostasis: implications of basal glycaemia in type 2 diabetes*
LeRoith, D., & Smith, D. O. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00278.x · Cited by 2
Infant nutrition and subsequent risk of Type 2 (non-insulin-dependent) diabetes mellitus
Dowse, G. K., & Hales, C. N. (1993) · Diabetologia · doi:10.1007/bf00399962 · Cited by 2
Abletshauser, C., Brunel, P., Usadel, K.-H., & Hanefeld, M. (2005) · The British Journal of Diabetes · doi:10.1177/14746514050050020701 · Cited by 2
Paulo, S. (2005) · Cited by 2
Inappropriate Use of High-Dose Glyburide to Treat Uncontrolled Type 2 Diabetes Mellitus
Rae, C. E., Ewing, R. C., & Cook, D. D. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700204 · Cited by 2
Parkulo, T. D. (2014) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.265 · Cited by 2
Metadata
- Authors
- Mitrakou, A., Kelley, D., Mokan, M., Veneman, T., Pangburn, T., Reilly, J., & Gerich, J.
- Affiliations
- University of Pittsburgh (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1992-01-02
- Volume
- 326
- Issue
- 1
- Pages
- 22-29
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2330273698
- Cited by
- 595
- References
- 47
- Citations by year
- 2026: 12 · 2025: 5 · 2024: 9 · 2023: 11 · 2022: 15 · 2021: 15 · 2020: 13 · 2019: 13 · 2018: 14 · 2017: 20 · 2016: 12 · 2015: 27 · 2014: 25 · 2013: 18 · 2012: 19
- FWCI
- 21.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (7r37dk020411-19)
- National Institute of Diabetes and Digestive and Kidney Diseases (5R37 DK20411)
- National Center for Research Resources (M01RR000056, 5 M01 RR00056)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- impaired glucose tolerance, type 2 diabetes, hepatic glucose production, insulin secretion, hyperinsulinemia, glucagon, insulin/glucagon ratio, muscle glucose uptake, obesity, beta-cell dysfunction, insulin resistance
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucagon, Glucose Tolerance Test, Humans, Insulin, Islets of Langerhans, Liver, Male, Middle Aged, Muscles, Prediabetic State
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
